ENVIVA INC (EVA)

US29415B1035 - Common Stock

0.4198  +0.01 (+2.22%)

Fundamental Rating

2

EVA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 209 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of EVA have multiple concerns. EVA does not seem to be growing, but still is valued expensively.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

EVA had negative earnings in the past year.
EVA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EVA reported negative net income in multiple years.
Of the past 5 years EVA 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -11.74%, EVA is not doing good in the industry: 89.00% of the companies in the same industry are doing better.
The Return On Equity of EVA (-109.62%) is worse than 93.30% of its industry peers.
Industry RankSector Rank
ROA -11.74%
ROE -109.62%
ROIC N/A
ROA(3y)-3.96%
ROA(5y)-2.25%
ROE(3y)-28.14%
ROE(5y)-16.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 1.44%, EVA is doing worse than 84.21% of the companies in the same industry.
In the last couple of years the Gross Margin of EVA has declined.
The Profit Margin and Operating Margin are not available for EVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5Y-15.21%

More info and screens

2

2. Health

2.1 Basic Checks

EVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
EVA has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, EVA has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.16, we must say that EVA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of EVA (0.16) is worse than 71.29% of its industry peers.
A Debt/Equity ratio of 5.83 is on the high side and indicates that EVA has dependencies on debt financing.
With a Debt to Equity ratio value of 5.83, EVA is not doing good in the industry: 93.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.83
Debt/FCF N/A
Altman-Z 0.16
ROIC/WACCN/A
WACC3.08%

2.3 Liquidity

A Current Ratio of 1.42 indicates that EVA should not have too much problems paying its short term obligations.
EVA has a Current ratio (1.42) which is comparable to the rest of the industry.
EVA has a Quick Ratio of 1.06. This is a normal value and indicates that EVA is financially healthy and should not expect problems in meeting its short term obligations.
EVA has a Quick ratio (1.06) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.06

More info and screens

3

3. Growth

3.1 Past

The earnings per share for EVA have decreased strongly by -68.50% in the last year.
EVA shows a decrease in Revenue. In the last year, the revenue decreased by -0.20%.
The Revenue has been growing by 15.04% on average over the past years. This is quite good.
EPS 1Y (TTM)-68.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-936.36%
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y16.93%
Revenue growth 5Y15.04%
Sales Q2Q%-1.55%

3.2 Future

EVA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.17% yearly.
EVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.60% yearly.
EPS Next Y-148.2%
EPS Next 2Y6.01%
EPS Next 3Y14.13%
EPS Next 5Y-3.17%
Revenue Next Year-6.05%
Revenue Next 2Y1.19%
Revenue Next 3Y11.72%
Revenue Next 5Y10.6%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EVA is valued a bit more expensive than the industry average as 79.43% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 94.98

4.3 Compensation for Growth

EVA's earnings are expected to grow with 14.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.01%
EPS Next 3Y14.13%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVIVA INC

NYSE:EVA (10/3/2024, 8:11:14 PM)

0.4198

+0.01 (+2.22%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)09-13 2024-09-13/amc
Earnings (Next)10-30 2024-10-30/amc
Inst Owners57.12%
Inst Owner Change0%
Ins Owners21.27%
Ins Owner Change0%
Market Cap31.43M
Analysts45
Price Target4.08 (871.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)6.05%
DP-32.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-143.34%
Min EPS beat(2)-288.14%
Max EPS beat(2)1.47%
EPS beat(4)1
Avg EPS beat(4)-199.08%
Min EPS beat(4)-288.14%
Max EPS beat(4)1.47%
EPS beat(8)1
Avg EPS beat(8)-988.96%
EPS beat(12)2
Avg EPS beat(12)-666.21%
EPS beat(16)4
Avg EPS beat(16)-503.85%
Revenue beat(2)0
Avg Revenue beat(2)-5.65%
Min Revenue beat(2)-9.42%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-16.16%
Min Revenue beat(4)-43.89%
Max Revenue beat(4)-1.88%
Revenue beat(8)1
Avg Revenue beat(8)-12.45%
Revenue beat(12)2
Avg Revenue beat(12)-9.32%
Revenue beat(16)3
Avg Revenue beat(16)-8.99%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.1
P/tB 0.15
EV/EBITDA 94.98
EPS(TTM)-4.23
EYN/A
EPS(NY)-1.58
Fwd EYN/A
FCF(TTM)-4.42
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS15.11
BVpS4.14
TBVpS2.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.74%
ROE -109.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.44%
FCFM N/A
ROA(3y)-3.96%
ROA(5y)-2.25%
ROE(3y)-28.14%
ROE(5y)-16.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5Y-15.21%
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 5.83
Debt/FCF N/A
Debt/EBITDA 111.49
Cap/Depr 207.35%
Cap/Sales 23.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.06
Altman-Z 0.16
F-Score3
WACC3.08%
ROIC/WACCN/A
Cap/Depr(3y)226.42%
Cap/Depr(5y)192.31%
Cap/Sales(3y)21.08%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-936.36%
EPS Next Y-148.2%
EPS Next 2Y6.01%
EPS Next 3Y14.13%
EPS Next 5Y-3.17%
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y16.93%
Revenue growth 5Y15.04%
Sales Q2Q%-1.55%
Revenue Next Year-6.05%
Revenue Next 2Y1.19%
Revenue Next 3Y11.72%
Revenue Next 5Y10.6%
EBIT growth 1Y43.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1305.49%
EBIT Next 3Y202.11%
EBIT Next 5Y141.9%
FCF growth 1Y-88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-167.89%
OCF growth 3YN/A
OCF growth 5YN/A